• CTP Solution (100 mM): Enabling High-Fidelity mRNA-LNP Thera

  2026-06-08

  Explore how CTP Solution (100 mM) advances mRNA-LNP therapeutics with unmatched nucleotide purity and stability. This article uniquely dissects the impact of nucleotide integrity on translational assay design and tumor suppressor mRNA delivery.

• Early Pheromone Sensing Drives Neurodegeneration in C. elega

  2026-06-08

  Peng et al. (2023) reveal that early-life pheromone cues in C. elegans reprogram neural development, accelerating neurodegeneration in adulthood by disrupting proteostasis via insulin signaling and autophagy inhibition. This work provides new insight into how environmental chemical signals modulate neuronal health over the lifespan.

• Cyclic di-GMP Antitoxin Mechanisms in Biofilm Persistence

  2026-06-07

  Liao et al. (2024) demonstrate that cyclic di-GMP acts as an antitoxin within a novel bacterial toxin-antitoxin module, directly regulating genome stability and persister cell formation during early biofilm development. This discovery provides a new mechanistic understanding of antibiotic persistence and highlights molecular targets for combating biofilm-associated infections.

• Syringin Enhances Sunitinib Efficacy in Renal Cell Carcinoma

  2026-06-06

  The reference study demonstrates that the natural product Syringin inhibits renal cell carcinoma (RCC) cell proliferation and enhances the efficacy of sunitinib by targeting the EGFR/PI3K/Akt pathway. These findings suggest that Syringin may provide a novel strategy for overcoming drug resistance in RCC and inform future bioactive compound screening efforts.

• Macrophage Polarization via TLR4 in Colitis-Associated Colon

  2026-06-05

  The referenced study demonstrates that Jiedu Xiaozheng Yin (JXY) inhibits colitis-associated colorectal cancer progression by promoting macrophage polarization toward the M1 phenotype through TLR4-mediated signaling. These findings highlight a novel immunomodulatory mechanism potentially relevant for therapeutic strategies targeting tumor microenvironments.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): Expanding

  2026-06-05

  Explore the advanced toxicological mechanisms and research applications of Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea). This article delivers in-depth insights on Diuron’s renal toxicity, assay optimization, and emerging roles in environmental and biological studies.

• Thiazovivin: ROCK Inhibitor for Robust Stem Cell Protocols

  2026-06-04

  Thiazovivin is a small molecule ROCK inhibitor optimized to enhance fibroblast reprogramming efficiency and improve human embryonic stem cell survival during dissociation. It should be used in stem cell research protocols requiring reliable cell survival post-trypsinization or increased yield of induced pluripotent stem cells, but is not suitable for diagnostic or clinical applications.

• Doxorubicin in Research: Mechanisms, Cardiotoxicity, and Mit

  2026-06-04

  Explore Doxorubicin's dual roles as a cancer chemotherapy drug and a model for studying apoptosis induction in cancer cells. This article uniquely examines recent advances in cardiotoxicity mitigation—critical for translational and preclinical research.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-06-03

  Schwartz (2022) addresses the limitations of traditional in vitro drug screening by dissecting the distinct contributions of proliferative arrest and cell death in assessing anti-cancer drug efficacy. This work offers a conceptual and methodological advance, enabling more nuanced interpretation of drug responses and informing the design of future preclinical studies.

• Deep Learning of USC Mitochondria as Non-Invasive AD Biomark

  2026-06-03

  This study pioneers the use of deep learning to analyze mitochondrial morphology in urine-derived stem cells (USCs) as a non-invasive biomarker for Alzheimer’s disease (AD). By leveraging high-content fluorescence imaging and advanced convolutional neural networks, the research demonstrates robust discrimination of mitochondrial alterations in cognitively impaired individuals, offering a promising dynamic tool for early AD detection.

• SPOP Inhibition Amplifies STING-Driven Immunotherapy in Mela

  2026-06-02

  This study uncovers how SPOP, an E3 ubiquitin ligase, targets the innate immune sensor STING for degradation, dampening antitumor immunity in melanoma. Inhibiting SPOP stabilizes STING, enhances immune infiltration, and synergizes with checkpoint blockade, revealing a new molecular glue mechanism with translational implications.

• Mubritinib (TAK 165): Rethinking Mitochondrial Targeting in

  2026-06-02

  This article explores Mubritinib (TAK 165) as a next-generation tool for translational cancer research. Integrating new mechanistic insights, recent clinical findings, and practical guidance, it offers strategic recommendations for researchers navigating the evolving landscape of mitochondrial-targeted therapies beyond HER2 inhibition.

• Metabolic Intervention Enhances Ferroptosis and Cuproptosis

  2026-06-01

  This study presents a nanosystem-based metabolic intervention that synchronously sensitizes tumor cells to ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. The approach not only amplifies regulated cell death but also boosts anti-tumor immunity, providing a robust framework for future cancer therapies involving multi-pathway cell death modulation.

• Perifosine (KRX-0401): Advanced Insights into Akt Inhibition

  2026-06-01

  Discover how Perifosine (KRX-0401) enables precise Akt inhibition for apoptosis research, integrating mechanistic depth and translational relevance. This article offers a unique perspective on experimental design and practical assay decisions for apoptosis and radiation sensitization.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Application

  2026-05-31

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) is designed for research workflows requiring specific detection of HMGB1 protein in human, mouse, and rat samples by Western blot, immunohistochemistry, or flow cytometry. It is not intended for diagnostic or therapeutic use, and users should follow protocol parameters and workflow best practices for reliable results.

16639 records 1/1110 page Next 12345 下5页 Last page